Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by unclepiemanon Jan 18, 2018 8:36pm
128 Views
Post# 27390121

A story of another ...

A story of another ...2003, invested in PIX.v (PEER1Network), a vancouver tech company... shares as cheap as 120 cents.

Took almost until 2007 for it to really move (I wish i had historic charts, if anyone can get it... please add a link). Then it took another 3 years for it to play in the $2 range, then got pushed to $3 and in 2012, company got bought out for .5 Billion $ and $4/share for private purchase.

point is ... 10 years to go from 20 cents to $4 and PIX.v was not groundbreaking of any sort. It was a service company that provided internet, something that hundreds of other companies did and still do.

BTI has two things, One is great and 2nd "CAN" be magical. 

1st one is the ability for big pharma to save their drug from going generic for another 10 years, the licencing from that alone could be huge millions.

2nd one is the show stopper, what we are all here for. The magic of making a druge more safe, less side effects, better utilization. Yes, I know what BTI is and how the delivery system works... By pharma using lower dossages due to high delivery concentration of the drug using BTI's delivery system, it makes the drug far more safer and managable. Not to mention less drug profile to use which means more $ saved for pharma.

Are we still in stages of risk? 100% YES! thats why the price of the stock is .67 and not $20.
Bullboard Posts